期刊文献+

白细胞介素-22在2型糖尿病患者外周血中的表达及意义 被引量:2

Expression and significance of interleukin-22 in peripheral blood of patients with type 2 diabetes mellitus
下载PDF
导出
摘要 目的了解2型糖尿病(T2DM)患者外周血中白细胞介素-22(IL-22)、白细胞介素-22结合蛋白(IL-22BP)水平的变化及其临床意义。方法选取T2DM患者90例作为T2DM组研究对象,另选取40名正常健康人作为对照组。酶联免疫吸附法检测各组IL-22、IL-22BP含量,同时测定一般生化指标及糖尿病慢性并发症筛查。结果与正常对照组相比,T2DM组IL-22表达水平降低(P<0.001),而IL-22BP水平升高(P<0.01)。相关性分析显示,IL-22与IL-22BP、踝/臂血压比值(ABI)呈负相关(ρ=-0.273、-0.312,P<0.01),与腰臀比(WHR)、空腹血糖(FPG)、糖化血红蛋白(HbA1C)、胰岛素抵抗指数(HOMA-IR)呈正相关(ρ=0.209、0.282、0.243、0.241,P<0.05),IL-22BP与HbA1C、低密度脂蛋白胆固醇(LDL-C)呈不同程度负相关(ρ=-0.290、-0.208,P<0.05)。Logistic回归分析显示IL-22及IL-22BP水平是T2DM发病的相关因素。合并糖尿病肾脏病变组较无糖尿病肾脏病变组IL-22表达下降(P<0.01)而IL-22BP表达增加(P<0.05)。结论T2DM患者外周血清中IL-22表达降低而IL-22BP表达升高,IL-22及IL-22BP表达与血糖控制、T2DM及糖尿病肾脏病变发生具有一定的相关性。 Objective To investigate the changes and clinical significance of interleukin-22(IL-22)and interleukin-22 binding protein(IL-22 BP)in peripheral blood of patients with type 2 diabetes mellitus(T2 DM).Methods A total of 90 patients with T2 DM were selected as the research objects of type 2 diabetes group,and another 40 normal healthy people were selected as the control group.The levels of IL-22 and IL-22 BP were measured by enzyme-linked immunosorbent assay(ELISA),and biochemical indexes and chronic complications were recorded.Results Compared with the normal control group,the level of IL-22 expression in T2 DM group was lower(P<0.001),while the level of IL-22 BP was higher(P<0.01).Correlation analysis showed that IL-22 was negatively correlated with IL-22 BP and ankle brachial index(ABI)(ρ=-0.273,-0.312,P<0.01),positively correlated with waist hip ratio(WHR),fasting plasma glucose(FPG),glycosylated hemoglobin(HbA1 C)and homeostasic model assessment of insulin resistance(HOMA-IR)(ρ=0.209,0.282,0.243,0.241,P<0.05),IL-22 BP was negatively correlated with HbA1 C and low density lipoprotein cholesterol(LDL-C)to different degrees(ρ=-0.290,-0.208,P<0.05).Logistic regression analysis showed that IL-22 and IL-22 BP levels were related factors for the pathogenesis of T2 DM.Compared with non-diabetic nephropathy group,the expression of IL-22 in diabetic nephropathy group decreased(P<0.01),while the expression of IL-22 BP increased(P<0.05).Conclusion The level of IL-22 expression decreases and IL-22 BP expression increases in type 2 diabetic patients,which may be related to blood glucose control,T2 DM and diabetic nephropathy.
作者 钱瑶 薛君力 曾姣娥 Qian Yao;Xue Junli;Zeng Jiaofe(Clinical Medical College,Yangtze University,Jingzhou 434020;Dept of Endocrinology,Jingzhou Central Hospital,Jingzhou 434020)
出处 《安徽医科大学学报》 CAS 北大核心 2020年第7期1117-1121,共5页 Acta Universitatis Medicinalis Anhui
基金 湖北省自然科学基金(编号:2017CFB735) 湖北省卫生计生科研基金(编号:WJ2016-YZ-06)。
关键词 IL-22 IL-22BP 2型糖尿病 糖尿病并发症 interleukin-22 interleukin-22 binding protein type 2 diabetes mellitus diabetic complication
  • 相关文献

参考文献3

二级参考文献82

  • 1王爱红,许樟荣,王玉珍,陈平,刘彧.有心血管危险因素的老年糖尿病患者有更高的下肢动脉病变患病率[J].老年医学与保健,2005,11(3):147-149. 被引量:22
  • 2谷涌泉,张建,齐立行,郭连瑞,张淑文,廖传军,李建新,俞恒锡,李学锋,崔世军,罗涛,杨盛家,陈兵,汪忠镐.不同移植浓度自体骨髓干细胞治疗下肢缺血临床疗效的影响[J].中国修复重建外科杂志,2006,20(5):504-506. 被引量:49
  • 3管珩,刘志民,李光伟,郭晓蕙,许樟榕,邹大进,邢惠莉,刘伟,盛正妍,田浩明,朱大龙,于德民,庄维特,陈璐璐,翁建平.50岁以上糖尿病人群周围动脉闭塞性疾病相关因素分析[J].中华医学杂志,2007,87(1):23-27. 被引量:120
  • 4谷涌泉,张建,俞恒锡,李建新,齐立行,李学锋,郭连瑞,崔世军,罗涛,陈兵,齐一侠,吴英锋,佟铸,汪忠镐.膝下动脉腔内成形术治疗严重下肢缺血[J].中华普通外科杂志,2007,22(2):123-125. 被引量:63
  • 5Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalenceof diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010; 87: 4-14[PMID: 19896746 DOI: 10.1016/j.diabres.2009.10.007].
  • 6World Health Organization. Diabetes Action Now: An Initiativeof the World Health Organization and the International DiabetesFederation. Switzerland: World Health Organization, 2004.
  • 7Stefánsson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E.Screening and prevention of diabetic blindness. Acta OphthalmolScand 2000; 78: 374-385 [PMID: 10990036 DOI: 10.1034/j.1600-0420.2000.078004374.x].
  • 8Prokofyeva E, Zrenner E. Epidemiology of major eye diseasesleading to blindness in Europe: a literature review. Ophthalmic Res2012; 47: 171-188 [PMID: 22123077 DOI: 10.1159/000329603].
  • 9Hammes HP. Optimal treatment of diabetic retinopathy. Ther AdvEndocrinol Metab 2013; 4: 61-71 [PMID: 23626903 DOI: 10.1177/2042018813477886].
  • 10Deutsche DG. Nationale VersorgungsLeitlinie Typ-2-DiabetesPr-vention und Therapie von Netzhautkomplikationen. Berlin:Bundes-rztekammer (B-K), 2010: 1-42.

共引文献459

同被引文献10

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部